Your browser doesn't support javascript.
loading
Multicentered Assessment of Clinical Outcomes and Factors Associated With Failure of the Adjustable TransObturator Male System (ATOMS).
Redmond, Elaine J; Nadeau, Genevieve; Tu, Le-Mai; Doiron, R Christopher; Steele, Stephen S; Herschorn, Sender; Locke, Jennifer A; Maciejewski, Conrad C; Dwyer, Neil T; Campeau, Lysanne; Carlson, Kevin V; Rourke, Keith F.
Afiliación
  • Redmond EJ; Division of Urology, University of Alberta, Edmonton, Alberta, Canada.
  • Nadeau G; Division of Urology, Université Laval, Quebec, Canada.
  • Tu LM; Division of Urology, University of Sherbrooke, Quebec, Canada.
  • Doiron RC; Department of Urology, Queen's University, Ontario, Canada.
  • Steele SS; Department of Urology, Queen's University, Ontario, Canada.
  • Herschorn S; Division of Urology, University of Toronto, Ontario, Canada.
  • Locke JA; Division of Urology, University of Toronto, Ontario, Canada.
  • Maciejewski CC; Division of Urology, University of Ottawa, Ontario, Canada.
  • Dwyer NT; Dalhousie University, Nova Scotia, Canada.
  • Campeau L; McGill University, Quebec, Canada.
  • Carlson KV; University of Calgary, Alberta, Canada.
  • Rourke KF; Division of Urology, University of Alberta, Edmonton, Alberta, Canada. Electronic address: krourke@ualberta.ca.
Urology ; 148: 280-286, 2021 02.
Article en En | MEDLINE | ID: mdl-33181122
ABSTRACT

OBJECTIVE:

To assess postoperative outcomes from the Adjustable TransObturator Male System (ATOMS) and identify factors influencing failure to achieve continence. PATIENTS AND

METHODS:

A multicentered analysis was performed on all patients treated for postprostatectomy incontinence using the third-generation ATOMS at 9 Canadian tertiary referral centers. The primary outcome was continence (defined as requiring ≤1 pad postoperatively for patients requiring ≥2 pads preoperatively and 0 pads for those requiring 1 pad preoperatively). Secondary outcomes included improvement (>50% change in pad use), patient satisfaction, explantation, and postoperative complications.

RESULTS:

Two hundred and eighty nine patients with a mean age of 68.9 years were analyzed. Pre-operatively mean pad per day use was 4.2 (1-12), 31.5% of patients reported severe incontinence (≥5 pads/day), 33.9% had concurrent radiotherapy and 19.4% had failed previous incontinence surgery. Overall continence rate was 73.3% (n = 212) at a mean follow-up of 19.6 months. More than eighty nine percent (89.3%) (n = 258) of patients experienced >50% improvement, 84.4% (n = 244) of patients were satisfied with the results of surgery. More than seven percent (7.9%) (n = 23) required device explantation. On multivariate Cox regression analysis, concurrent radiotherapy (hazard ratio [H.R.] 2.3, P < .001), diabetes (H.R. 2.2, P = .007) and increased pre-operative pad usage (H.R. 1.1, P = .02) were each associated with failure to achieve continence, while patient age (P = .60), obesity (P = .08), prior urethral stenosis (P = .56), and prior incontinence surgery (P = .13) were not. Radiation therapy was also associated with device explantation (H.R. 2.7, P = .02).

CONCLUSION:

ATOMS is a safe and efficacious for treatment of postprostatectomy incontinence. However, patients with prior radiation, increased pre-operative pad use, or diabetes are less likely to achieve continence.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Complicaciones Posoperatorias / Prostatectomía / Incontinencia Urinaria / Falla de Prótesis / Cabestrillo Suburetral Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Urology Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Complicaciones Posoperatorias / Prostatectomía / Incontinencia Urinaria / Falla de Prótesis / Cabestrillo Suburetral Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Urology Año: 2021 Tipo del documento: Article